New Delhi: The Centre plans to extend the deadline for complying with good manufacturing practice, at par with the World Health Organization standards, for small pharmaceutical companies with a revenue of ₹250 crore or less less by one year till 31 December 2025. This comes in the backdrop of several respresentations sumbitted to the government by various associations requesting extension …
The Union Health Ministry recently published a new draft Bill to replace the antiquated Drugs and Cosmetics Act, 1940. The federalism question The one issue that has come up in every review of the drug regulatory system since 1947 has been the uneven enforcement of the Drugs and Cosmetics Act across India. This is because, unlike the U.S. which has …
